Patrick W. Serruys

Showing 1-20 of 502 articles

Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial

Seth A, Onuma Y, Chandra P, Bahl V, Manjunath C, Mahajan A, Kumar V, Goel P, Wander G, Kaul U, Ajit Kumar V, Abizaid A, Serruys PW

May 23, 2019 | 10.4244/EIJ-D-19-00324

Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry

Modolo R, Chang C-C, Tateishi H, Miyazaki Y, Pighi M, Abdelghani M, Roos M, Wolff Q, Wykrzykowska J.J, de Winter R.J, Piazza N, Richardt G, Abdel-Wahab M, Soliman O, Onuma Y, Van Mieghem N, Serruys PW

May 23, 2019 | 10.4244/EIJ-D-19-00362

Coronary interventions

How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials

Katagiri Y, Serruys PW, Asano T, Miyazaki Y, Chichareon P, Modolo R, Takahashi K, Kogame N, Wykrzykowska J.J, Piek J, Onuma Y

May 20, 2019 | 10.4244/EIJ-D-18-00607

EuroIntervention and EuroPCR 2019 – together embodying the spirit of interventional cardiology

Serruys PW, Mylotte D, Capodanno D, Søndergaard L, Byrne R

May 20, 2019 | 10.4244/EIJV15I1A1

Coronary interventions

Serial comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polymer coated everolimus-eluting Xience stent: 6- and 24-month results of DESSOLVE III OCT sub-study

Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J.J, Wijns W, de Winter R.J, Buszman P, Onuma Y, Serruys PW

May 7, 2019 | 10.4244/EIJ-D-18-01201

Coronary interventions

Prasugrel monotherapy after PCI with the SYNERGY stent in patients with chronic stable angina or stabilized acute coronary syndromes: rationale and design of the ASET pilot study

Kogame N, Modolo R, Tomaniak M, Cavalcante R, de Martino F, Tinoco J, Ribeiro E, Mehran R, Campos C, Onuma Y, Lemos P, Serruys PW

April 23, 2019 | 10.4244/EIJ-D-19-00131

Interventions for valvular disease

Feasibility of quantitative assessment of aortic regurgitation in a percutaneous closure of paravalvular leak: expanding videodensitometry

Teixeirense PT, Modolo R, de Toledo JFB, Serruys PW

April 16, 2019 | 10.4244/EIJ-D-19-00118

Coronary interventions

Interventional cardiology 2018: the year in review

Komiyama H, Modolo R, Chang CC, Chichareon P, Kogame N, Takahashi K, Tomaniak M, Onuma Y, Cuisset T, Fajadet J, Amin H, Al Rashdan I, Serruys PW

April 5, 2019 | 10.4244/EIJ-D-19-00040

Interventions for valvular disease

The evolution of device technology in transcatheter aortic valve implantation

Bourantas C, Modolo R, Baumbach A, Søndergaard L, Prendergast B, Ozkor M, Kennon S, Mathur A, Mullen M, Serruys PW

April 5, 2019 | 10.4244/EIJ-D-18-01048

Coronary interventions

Significant association among residual SYNTAX score, non-culprit major adverse cardiac events, and greyscale and virtual histology intravascular ultrasound findings: a substudy from the PROSPECT study

Fujino A, Kadohira T, Redfors B, Maehara A, Serruys PW, Mintz G, Stone G.W., Généreux P

March 20, 2019 | 10.4244/EIJ-D-18-00681

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial

Serruys PW, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C-C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Edes I, van der Harst P, Krackhardt F, Thijssen J, Rademaker-Havinga T, Garg S, Steg P-G, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

March 17, 2019 | 10.4244/EIJ-D-19-00202

Coronary interventions

Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs

Onuma Y, Katagiri Y, Burzotta F, Holm N.R., Amabile N, Okamura T, Mintz G, Darremont O, Lassen JF, Lefèvre T, Louvard Y, Stankovic G, Serruys PW

February 7, 2019 | 10.4244/EIJ-D-18-00391

Coronary interventions

Two-year follow-up of the DESSOLVE III trial: bioabsorbable polymer sirolimus-eluting stent vs. durable polymer everolimus-eluting stent.

Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek J, Wykrzykowska J.J, Asano T, Kogame N, Takahashi K, Chang C-C, de Winter R.J, Serruys PW, Wijns W

February 5, 2019 | 10.4244/EIJ-D-18-00944

Coronary interventions

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iniguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K-L, Windecker S, Kastrati A, Serruys PW

February 5, 2019 | 10.4244/EIJ-D-18-01080

STEMI

SYNTAX score in relation to intravascular ultrasound and near-infrared spectroscopy for the assessment of atherosclerotic burden in patients with coronary artery disease

Vroegindewey MM, Schuurman A-S, Kardys I, Anroedh SS, Oemrawsingh R, Ligthart J, García-García HM, van Geuns R-J, Regar E, Van Mieghem N, Serruys PW, Boersma E, Akkerhuis K

January 18, 2019 | 10.4244/EIJ-D-17-00827

Offering a new and more accessible vision of interventional medicine

Serruys PW

January 18, 2019 | 10.4244/EIJV14I13A241

Coronary interventions

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with three-vessel disease:2-year follow-up of the SYNTAX II study

Serruys PW, Kogame N, Katagiri Y, Modolo R, Buszman P, Iniguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, Piek J, Wykrzykowska J.J, Escaned J, Banning A, Farooq V, Onuma Y

January 15, 2019 | 10.4244/EIJ-D-18-00980

Coronary interventions

A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial

Asano T, Jin Q, Katagiri Y, Kogame N, Takahashi K, Chang C-C, Chichareon P, Wang C, Shi B, Su X, Fu G, Wu Y, Zhou X, Yuan Z, Wykrzykowska J.J, Piek J, Serruys PW, Onuma Y, Chen Y

December 20, 2018 | 10.4244/EIJ-D-18-00461

Coronary interventions

Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)

Katagiri Y, Onuma Y, Asano T, Iniguez A, Jensen LO, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys P, Räber L, Sabaté M, Serruys PW

December 7, 2018 | 10.4244/EIJ-D-18-00839

Coronary interventions

Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All Comers

Baumbach A, Lansky A, Onuma Y, Asano T, Johnson T, Anderson R, Kiemeneij F, Zheng M, van Royen N, Slagboom T, Vlachojannis G, Serruys PW, Wijns W

November 20, 2018 | 10.4244/EIJ-D-18-00226

Latest news

Late breaking trials

Hot off the press: access today’s Late Breaking Trials - EuroPCR 2019

May 21, 2019

New issue

EuroPCR 2019 issue: Basilica, new BRS generation, EBC Consensus and much more! Available now!

(Cover Image: 3 requirements for optimal traversal system positioning)

May 20, 2019

JAA

"Shocktopics" and Coronary IVL in the JAA of the week

May 21, 2019

Guidance papers

Guidelines, consensus & position papers

April 9, 2019

Guidance papers

14th Consensus from the European Bifurcation Club

May 20, 2019

Editorial

The art of educating a fellow: a “mother-and-child” relationship

May 20, 2019

EAPCI column

The year ahead: EAPCI milestones by Andreas Baumbach

May 20, 2019

Patrick W. Serruys

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke